Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 27Active not recruiting 17Completed 10Not yet recruiting 9Terminated 4Unknown 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × trastuzumab deruxtecan × Clear all
NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1/2 Unknown
120 enrolled
Breast

Breast Neoplasms

NCT06135194 2023-11-18

Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Beijing 302 Hospital

Unknown
30 enrolled
Breast

Breast Neoplasms

NCT05594082 2023-04-04

Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer

Fudan University

Unknown
150 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡